Despite the growth in the number of lung transplants performed in the United States, demand far exceeds organ supply. According to 2017 OPTN data, there were 2439 lung transplants; insufficient supply left over 1462 patients waiting for this life-saving procedure resulting in 194 deaths and 141 becoming too sick for transplantation while waiting. These numbers are inclusive of recipients who, as their conditions deteriorate, choose to receive lungs from less than ideal donors (ie, older donors, donors with significant smoking history). To meet the overwhelming demand, one strategy is to expand the donor pool to include lung donation when death occurs unexpectedly in or out-of-hospital settings, what is often termed uncontrolled donation after circulatory determination of death (uDCDD). Widespread dissemination of uDCDD programs could markedly improve supply of donor lungs for patients in need of transplants. The objective of this paper is to propose an ethical framework for transplant programs to facilitate lung uDCDD in the United States. Since 2000, European countries have utilized uDCDD to recover kidneys, livers, and lungs, leading to shorter wait times and thousands more saved lives. 1 Foreign studies suggest uDCDD lung transplant outcomes are within acceptable range with some Abbreviations: BDD, brain death donors; DSMBs, data safety monitoring boards; EVLP, ex-vivo lung perfusion; nECMO, normothermic extracorporeal membrane oxygenation;OPU, organ preservation unit; TOR, termination of resuscitation; uDCDD, uncontrolled donation after circulatory determination of death.